Zentalis Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - March 6, 2020

Attached files

file filename
EX-21.1 - EX-21.1 - Zentalis Pharmaceuticals, Inc.d827765dex211.htm
EX-10.20 - EX-10.20 - Zentalis Pharmaceuticals, Inc.d827765dex1020.htm
EX-10.19 - EX-10.19 - Zentalis Pharmaceuticals, Inc.d827765dex1019.htm
EX-10.18 - EX-10.18 - Zentalis Pharmaceuticals, Inc.d827765dex1018.htm
EX-10.17 - EX-10.17 - Zentalis Pharmaceuticals, Inc.d827765dex1017.htm
EX-10.16 - EX-10.16 - Zentalis Pharmaceuticals, Inc.d827765dex1016.htm
EX-10.15 - EX-10.15 - Zentalis Pharmaceuticals, Inc.d827765dex1015.htm
EX-10.14 - EX-10.14 - Zentalis Pharmaceuticals, Inc.d827765dex1014.htm
EX-10.13 - EX-10.13 - Zentalis Pharmaceuticals, Inc.d827765dex1013.htm
EX-10.12 - EX-10.12 - Zentalis Pharmaceuticals, Inc.d827765dex1012.htm
EX-10.11 - EX-10.11 - Zentalis Pharmaceuticals, Inc.d827765dex1011.htm
EX-10.10 - EX-10.10 - Zentalis Pharmaceuticals, Inc.d827765dex1010.htm
EX-10.9 - EX-10.9 - Zentalis Pharmaceuticals, Inc.d827765dex109.htm
EX-10.8 - EX-10.8 - Zentalis Pharmaceuticals, Inc.d827765dex108.htm
EX-10.7 - EX-10.7 - Zentalis Pharmaceuticals, Inc.d827765dex107.htm
EX-10.1 - EX-10.1 - Zentalis Pharmaceuticals, Inc.d827765dex101.htm
EX-4.2 - EX-4.2 - Zentalis Pharmaceuticals, Inc.d827765dex42.htm
EX-4.1 - EX-4.1 - Zentalis Pharmaceuticals, Inc.d827765dex41.htm
EX-3.3 - EX-3.3 - Zentalis Pharmaceuticals, Inc.d827765dex33.htm
S-1 - FORM S-1 - Zentalis Pharmaceuticals, Inc.d827765ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 6, 2020, in the Registration Statement on Form S-1 and related Prospectus of Zentalis Pharmaceuticals, LLC for the registration of shares of its common stock.

/s/ Ernst & Young LLP

San Diego, California

March 6, 2020

Zentalis Pharmaceuticals, Inc. Reports